Non-invasive Beta-cell Imaging: Visualization, Quantification, and Beyond
Pancreatic beta (β)-cell dysfunction and reduced mass play a central role in the development and progression of diabetes mellitus. Conventional histological β-cell mass (BCM) analysis is invasive and limited to cross-sectional observations in a restricted sampling area. However, the non-invasive eva...
Main Authors: | Takaaki Murakami, Hiroyuki Fujimoto, Nobuya Inagaki |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.714348/full |
Similar Items
-
Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
by: Takaaki Murakami, et al.
Published: (2020-11-01) -
Noninvasive longitudinal quantification of β-cell mass with [111In]-labeled exendin-4
by: Fujita, Naotaka
Published: (2020) -
Extrapancreatic insulinoma
by: Robin Garg, et al.
Published: (2020-01-01) -
First-in-Human Evaluation of Positron Emission Tomography/Computed Tomography With [18F]FB(ePEG12)12-Exendin-4: A Phase 1 Clinical Study Targeting GLP-1 Receptor Expression Cells in Pancreas
by: Hiroyuki Fujimoto, et al.
Published: (2021-08-01) -
Positron emission tomography quantification of stem cells in cardiovascular disease
by: Dietz, Bryson
Published: (2014)